2021
-
August 10, 2021 Management & Finance PDF215 KB
Outline of Consolidated Financial Results for the First Quarter Ended June 30, 2021
-
July 14, 2021 Corporate PDF270 KB
-
July 01, 2021 Pharmaceuticals PDF299 KB
-
June 25, 2021 Pharmaceuticals PDF262 KB
Submission of New Drug Application for NS-065/NCNP-01 (viltolarsen) in China
-
June 21, 2021 Pharmaceuticals PDF263 KB
-
May 14, 2021 Management & Finance
Outline of Consolidated Financial Results for the Year Ended March 31, 2021
-
May 12, 2021 Pharmaceuticals PDF261 KB
-
March 23, 2021 Pharmaceuticals PDF263 KB
(Media)MHLW approval of Vidaza(azacitidine) for the Treatment of Acute Myeloid Leukemia
-
March 18, 2021 Management & Finance PDF233 KB
-
March 16, 2021 Management & Finance PDF311 KB
(Media)Nippon Shinyaku Announces Changes to Representative Directors and Members of the Board
-
February 08, 2021 Management & Finance
Outline of Consolidated Financial Results for the Third Quarter Ended December 31, 2020